腹腔透析患者血清尿酸和胃肠道出血之间的关系:倾向性评分分析
Guowen Zhao1, Yijia Zheng1, Na Tian2
1Department of Hematology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Renal failure
|October 1, 2024
概括
高尿酸水平是腹腔透析患者胃肠道出血的重要危险因素. 质子抑制剂可能会降低尿酸升高的患者的出血风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 胃肠病学 胃肠病学
背景情况:
- 胃肠道出血是腹腔透析 (PD) 患者的严重并发症,增加死亡风险.
- 尿酸水平升高在PD患者中很常见,并且与其他不良结果,如出血性中风有关.
研究的目的:
- 为了研究血清尿酸水平与腹腔透析患者的胃肠道出血 (GIB) 之间的关联.
主要方法:
- 分析了2498名PD患者的队列,与1762名患者的倾向性得分匹配子组进行了分析.
- 限制立方线和多变量考克斯回归模型评估了尿酸水平与GIB风险之间的相关性.
- 卡普兰-梅尔曲线和森林地块评估了生存结果和子组相互作用.
主要成果:
- 血清尿酸水平与胃肠道出血事件的风险有正相关性.
- 高尿酸水平独立地增加了GIB的风险 (HR 1.868,95%CI 1.001-3.486) 经过对混因素进行调整后.
- 质子抑制剂的使用与尿酸水平显著相互作用,降低高尿酸患者的GIB风险.
结论:
- 血清尿酸基线升高是腹腔透析患者胃肠道出血的独立危险因素.
- 质子抑制剂可以减轻高尿酸水平的PD患者GIB的风险.
相关概念视频
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
2
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
2
Peptic Ulcer Disease I: Introduction
141
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
141
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356
Serum Studies: Renal Function Tests
1
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
1
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
94
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
94


